CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner as the health care giant continues to ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. CVS Health also warned of disappointing third-quarter ...

The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...

The Food and Drug Administration may soon propose new labels for foods deemed high in sodium, sugar or fat. Today, we unpack the mounting “food fight” over the plan amid a growing obesity crisis.

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Rhyee from TD Cowen upgraded the rating on the stock to a Buy and ...

“It was all meant to be: exit 420, a big cannabis clinic, big cannabis pharmacy and then we turned Takapuna into the hub of medicinal ... Foundation analysis of NZ Health data in 2020 estimated ...

CVS Health announced that it will cut 2,900 jobs as part of a cost-cutting plan. The layoffs will mostly affect corporate positions, a CVS spokesperson told FOX Business. More than 300,000 people ...

CVS Health is planning to cut about 2,900 jobs in an effort to slash costs, the U.S. health care company said Tuesday.“We’ve embarked on a multi-year initiative to deliver $2 billion in cost ...

CVS Health revised its adjusted EPS guidance to $6.40-$6.65 from at least $7.00 versus the consensus of $6.98, reflecting continued pressure in the Health Care Benefits segment.

Barclays analyst Andrew Mok CFA maintained a Hold rating on CVS Health (CVS – Research Report) today and set a price target of $63.00. The company’s shares closed yesterday at $62.88.